QSV Biologics Awarded cGMP Manufacturing Contract by Pfizer Inc.
EDMONTON, Canada, May 1/PRNewswire/ -- QSV Biologics, Ltd (QSV), a North American based biologics CMO located in
Edmonton, Canada, has been awarded a cGMP manufacturing contract for a
recombinant protein under development by Pfizer, Inc. The protein will be
manufactured at QSV's Edmonton facility and is intended for clinical trials.
Work on the project is to begin immediately, and will include technology
transfer, scale-up and cGMP manufacturing.
Graeme Macaloney PhD, PEng, Founder, President & CEO of QSV said: "We are
extremely pleased and honoured that Pfizer has chosen QSV Biologics from a
strong field of contending CMOs as their manufacturing partner for this
project. The execution of this contract is the culmination of extended
evaluations by the Pfizer organization, reflecting QSV's continuing
dedication to quality, speed and value. This project is an extremely good fit
for our capabilities and indicative of our ability to respond to the
challenging requirements of respected companies like Pfizer."
"Pfizer is pleased to engage QSV for the clinical manufacturing of a
complex biotechnology product," said Rick Rutter, Ph.D., Vice President of
Global Biologics in the Pharmaceutical Sciences division of Pfizer Global
Research and Development. "Speed to clinic is of great importance for early
development candidates and QSV has a record of delivering quality product
on-time and on-budget. QSV will play a supporting role in realizing Pfizer's
vision of becoming a top tier biotherapeutic company."
QSV Biologics, Ltd. (http://www.qsvbiologics.com), is an international
cGMP biologics contract manufacturer (CMO) providing microbial fermentation &
cell culture, and purification services. QSV's facility has a 12 yr track
record including an Establishment License for manufacturing clinical trial
and commercial biologics. QSV was the sole recipient of the prestigious
international Frost & Sullivan "Customer Value Enhancement Award" in 2005 and
the BioAlberta "Company of the Year Award" in 2007. QSV's global clientele
spans 3 continents and develops protein therapeutics, vaccines & diagnostics.
As a dedicated CMO with no competing products of its own, QSV builds value
for its clients by producing quality products in a timely manner. Hence its
acronym: QSV: Quality & Speed build Value.
For further information:
Richard Hetrick, M.Sc., B.Sc., Director of Business Development,
QSV Biologics, Ltd.,
Ph: +1-780-438-5722 Ext. 1,
Email: Rhetrick@QSVBiologics.com
Source: QSV Biologics, Ltd
For further information: Richard Hetrick, M.Sc., B.Sc., Director of Business Development, QSV Biologics, Ltd., Ph: +1-780-438-5722 Ext. 1, Email: Rhetrick@QSVBiologics.com
2008-05-01 19:13:46 0351122 PRNEWSWIRE